Not Tagged
Not Tagged
['detection', 'biomarker']
opportunities for ctdna:
- guide treatment decisions via molecular profiling
- potential to identify patients who are responding earlier
- molecular (minimal) residual disease (mrd) as a prognostic biomarker
- potential for early detection (sensitivity may be limiting)
#asco22 
passionate about connecting scientists and advocates to improve #cancerresearch and #healthpolicy || science policy analyst at @cancerresrch || tweets = my own